Pharmacytimes: Condition Center: COPD COPD en-us Tue, 25 Apr 2017 06:09:48 UTC Tue, 25 Apr 2017 06:09:48 UTC 5 COPD Studies Every Pharmacist Should Know Over the years, a number of landmark clinical studies on COPD have been published, shaping how we treat the disease today. 10:12 PM, Sun April 2, 2017 Stiff Competition to Create a Smarter Inhaler 3M Drug Delivery Systems will be working to introduce its Intelligent Inhaler to the market by developing a partnership with pharmaceutical companies. 11:14 PM, Sun July 10, 2016 New COPD Maintenance Treatment Approved The FDA has approved AstraZeneca’s glycopyrrolate and formoterol fumarate (Bevespi Aerosphere) inhalation aerosol for long-term maintenance treatment for patients with chronic obstructive pulmonary disease. 7:00 AM, Mon May 2, 2016 Why Are COPD Patients Afraid to Exercise? Patients with chronic obstructive pulmonary disease have reductions in their brains’ gray matter related to the processing of dyspnea, fear, and sensitivity to painful stimuli. 10:12 PM, Wed March 30, 2016 A Quick Overview of COPD Treatment Options Treating COPD can be a complex undertaking. 1:51 AM, Wed March 2, 2016 Pocket-Sized Asthma Inhaler Under Development Imagine if your metered-dose inhaler could fit into your wallet. 11:38 PM, Sun February 28, 2016 Pharmacy Interventions Can Improve COPD Exacerbations Nonadherence to chronic obstructive pulmonary disease treatment worsens patient health outcomes and increases related costs. 11:09 PM, Tue February 23, 2016 Imminent Influx of Generic COPD Inhalers Will Require Pharmacist Input A host of new inhalers for chronic obstructive pulmonary disease are nearing market entry. 1:00 AM, Fri January 29, 2016 Can Music Benefit COPD Patients? Pharmacists may want to encourage their patients with chronic obstructive pulmonary disease to complement their pharmacologic treatment with music therapy. 10:00 PM, Tue December 29, 2015 The New Age of Inhalation Over the past few years, a multitude of new inhalation devices that are not your standard point-and-press inhalers have come onto the market.  11:46 PM, Sun December 27, 2015 COPD Controller Combo May Lower Death Risk Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk. 7:00 AM, Mon November 30, 2015 3 COPD Symptoms That Could Predict Hospitalization For patients with chronic obstructive pulmonary disease (COPD), fear during episodes of breathlessness, dyspnea during typical daily activities, and depressive symptoms may be good predictors of hospitalization. 11:00 PM, Thu October 29, 2015 2 Novartis COPD Treatments Nab FDA Nod The FDA has approved 2 Novartis inhalation powders for the treatment of COPD. 10:11 PM, Thu October 29, 2015 Comorbid Asthma and COPD: Common and Costly Asthma and chronic obstructive pulmonary disease (COPD) occur together at an alarming rate. 8:00 AM, Wed September 30, 2015 Spiriva Respimat Now Approved for Asthma The FDA has added an asthma indication to Boehringer Ingelheim's tiotropium bromide inhalation spray (Spiriva Respimat). 8:00 AM, Fri September 18, 2015 Navigating New COPD Medications Several advancements have been made in COPD medication classes. 11:04 PM, Wed September 2, 2015 8 Debilitating Diseases: How Pharmacists Can Help A list of the most debilitating diseases a patient may face over his or her lifetime was recently curated by Healthcare Business and Technology. 8:00 AM, Tue September 1, 2015 Dispensing Multidose COPD Inhalers at Discharge Improves Medication Adherence Multidose medication dispensing at discharge (MMDD) involves supplying products that have been partially used during hospitalization to ensure continuity of care. 12:55 AM, Mon August 31, 2015 Digital Health Transforming Inhalers There are immense oppurtunities to transform the inhaler into a tool that tracks patients' use of asthma and COPD medications. 9:06 PM, Tue August 25, 2015 Bacterial Pneumonia Treatment Fast-Tracked by FDA The FDA has fast-tracked Cempra's solithromycin to treat community acquired bacterial pneumonia. 10:29 PM, Sun August 23, 2015